Next Article in Journal
Association of Serum Adiponectin Biomarker with Metabolic Syndrome Components in Koreans with Extremely High HDL Cholesterol Levels in General Health Checkup
Previous Article in Journal
Making “Sense” of Ecology from a Genetic Perspective: Caenorhabditis elegans, Microbes and Behavior
Previous Article in Special Issue
Comparison of Lysis and Detachment Sample Preparation Methods for Cultured Triple-Negative Breast Cancer Cells Using UHPLC–HRMS-Based Metabolomics
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Metabolites
Volume 12
Issue 11
10.3390/metabo12111085
metabolites-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Isotopic Tracer for Absolute Quantification of Metabolites of the Pentose Phosphate Pathway in Bacteria

by
Khairunnisa Mohd Kamal
1,
Mohd Hafidz Mahamad Maifiah
1,*,
Yan Zhu
2,
Nusaibah Abdul Rahim
3,
Yumi Zuhanis Has-Yun Hashim
1 and
Muhamad Shirwan Abdullah Sani
1
1
International Institute for Halal Research and Training (INHART), International Islamic University Malaysia (IIUM), Jalan Gombak 53100, Selangor, Malaysia
2
Infection and Immunity Program, Department of Microbiology, Biomedicine Discovery Institute, Monash University, Victoria 3800, Australia
3
Faculty of Pharmacy, University of Malaya, Kuala Lumpur 50603, Selangor, Malaysia
*
Author to whom correspondence should be addressed.
Metabolites 2022, 12(11), 1085; https://doi.org/10.3390/metabo12111085
Submission received: 27 August 2022 / Revised: 2 November 2022 / Accepted: 7 November 2022 / Published: 9 November 2022
(This article belongs to the Special Issue Sample Preparation in Metabolomics Volume II)
Browse Figures
Versions Notes

Abstract

:
The pentose phosphate pathway (PPP) plays a key role in many metabolic functions, including the generation of NADPH, biosynthesis of nucleotides, and carbon homeostasis. In particular, the intermediates of PPP have been found to be significantly perturbed in bacterial metabolomic studies. Nonetheless, detailed analysis to gain mechanistic information of PPP metabolism remains limited as most studies are unable to report on the absolute levels of the metabolites. Absolute quantification of metabolites is a prerequisite to study the details of fluxes and its regulations. Isotope tracer or labeling studies are conducted in vivo and in vitro and have significantly improved the analysis and understanding of PPP. Due to the laborious procedure and limitations in the in vivo method, an in vitro approach known as Group Specific Internal Standard Technology (GSIST) has been successfully developed to measure the absolute levels of central carbon metabolism, including PPP. The technique adopts derivatization of an experimental sample and a corresponding internal standard with isotope-coded reagents to provide better precision for accurate identification and absolute quantification. In this review, we highlight bacterial studies that employed isotopic tracers as the tagging agents used for the absolute quantification analysis of PPP metabolites.

1. Introduction

The pentose phosphate pathway (PPP) is crucial in many cellular metabolic functions. The pathway is important for amino acid and nucleotide biosynthesis, metabolic processes regulation, oxidative stress and redox homeostasis prevention, and stress response activation [1,2,3]. PPP is required for regulating energy metabolism by producing nicotinamide adenine dinucleotide phosphate (NADPH), adapting metabolic reconfiguration in the cell cycle, generating response signaling pathways in cancer metabolism, and in host-pathogen interactions of parasitic protozoa and bacterial infections [1,2,4]. Studies also discovered that the metabolites of PPP are responsible for the regulation of human clear cell-renal cell carcinoma (ccRcc) redox homeostasis [5], type 2 diabetes mellitus [6], and as biomarkers of pancreatic cancer [7]. Recent findings reported significant perturbations of PPP metabolism in pathogenic bacteria upon antibiotic treatment [8,9,10,11].
PPP metabolism has been well studied over the years using various methods of analysis to gain an in-depth understanding of its function and regulation. Nonetheless, detailed understanding of the mechanistic information of PPP remains the interest of much research as most studies are unable to record the absolute quantification analysis of its intermediate metabolites. The absolute concentration levels of metabolites of PPP immediately reflect the actual metabolic conditions of a cellular system. A number of quantification methods have been used to measure the levels of targeted metabolites, but each comes with some limitations. The major challenges are due to the rapid turnover rates of the intermediates, with low abundances and poor separation between the sugar phosphates during analysis [2]. The developed method based on the incorporation of isotopic tracers as tagging agents coupled with high-tech mass spectrometry (MS) has significantly improved the accuracy of quantitative analysis [12,13,14,15].
Isotope tracer or labeling is not an entirely new approach used in metabolite identification and quantification as well as in flux analysis [16]. Metabolite labeling refers to a method used for incorporating detection or affinity tags into biomolecules that can be performed via in vivo endogenous synthesis and in vitro [17]. The incorporation of isotopic tracer techniques coupled with advanced analytical instruments has offered great advantages to both untargeted and targeted metabolomic approaches [18]. The technique is robust, which provides better separation between the identical compounds of interest. It allows accurate identification and direct quantification of metabolites’ levels and determination of pathway fluxes [19,20], leading to novel biomarker discoveries and metabolic pathway mapping [18]. In this review, absolute quantification of PPP metabolites, notably in bacteria studies, is discussed using isotopic tracer methods. The scope of this review covers sample preparation procedures in vivo and in vitro isotopic labeling studies, but it does not go into detail about the analytical equipment used.

2. Pentose Phosphate Pathway

The metabolic reactions in PPP are divided into oxidative and non-oxidative phases, where the activities majorly occur in the latter phase [21]. The oxidative phase is essential for the conversion of glucose 6-phosphate into carbon dioxide, ribulose 5-phosphate, and NADPH, which explains the vastly active reactions in the majority of eukaryotes [2]. The non-oxidative phase plays roles in the ageing process, regulating redox balance during stress, yielding ribose 5-phosphate for synthesis of nucleic acids and amino acid precursors, and glycolysis [2]. Other significant metabolites in the non-oxidative phase are erythrose 4-phosphate and sedoheptulose 7-phosphate. The former is important for aromatic amino acids synthesis and vitamin B6 metabolism [2,4,22,23] while the latter connects the intermediates of the glycolysis pathway and the non-oxidative PPP phase [2]. An alternative L-type PPP involves other intermediates, including octulose 8-phosphate, but little is known about its details [24]. A number of studies have shown that PPP is significantly involved in many important metabolic processes, including in cancer [25], cell proliferation [26,27], brain energy metabolism [28], host-pathogen response [29], targeted pathway of drug treatment against parasitic and bacterial infection [30,31], biosynthesis of bacteria’s lipopolysaccharides [32], and central pathway for bacterial infection [33].
Many recent bacterial metabolomics studies revealed that the levels of PPP metabolites were significantly changed by antibiotic treatments, including gluconate 6-phosphate, D-ribose 5-phosphate, D-erythrose 4-phosphate, glyceraldehyde 3-phosphate, D-sedoheptulose 7-phosphate, D-glucono-1,5-lactone 6-phosphate, and D-fructose 1,6-biphosphate [8,9,10,34,35,36,37]. For example, global profiling of Acinetobacter baumannii and Pseudomonas aeruginosa treated with combinations of antibiotics demonstrated significantly reduced levels of D-ribose 5-phosphate, D-erythrose 4-phosphate, and D-sedoheptulose 7-phosphate over 1 h of treatment [8,9,10,34,38]. The findings are essential and a detailed understanding of the metabolic changes is further required as this potentially provides a novel strategy of metabolite-based treatment in addressing the issue of antimicrobial resistance. Though the detailed analysis is warranted, our literature search indicates that only a few publications, particularly of bacterial studies, reported the results in the form of absolute concentrations of PPP metabolites (Table 1).

3. Isotopic Tracer

Detailed pathway analysis and development of the kinetic model of a particular metabolic pathway requires an accurate and reliable method to quantify the absolute levels of metabolites involved. Various analysis methods used for metabolite quantification have been reported, including measuring released radioactive carbon dioxide [43], colorimetric assays [44,45], combination of thin layer chromatography with 14C-labeled substrates [46], fluorometric method by enzymatic interconversions [44,47], and feeding with isotope-labeled glucose [2]. Nonetheless, these methods have some limitations in that they are time consuming, complex, have low sensitivity and applicability, are not robust, and are ineffective for distinguishing between analytes in the oxidative and non-oxidative phases [2].
Isotopic labeling or tracer has been routinely used to identify and quantify the absolute levels of metabolites of interest [48]. Isotope-labeled compounds can be traced through the cellular metabolic pathways and reactions using appropriate analytical tools, including NMR and advanced MS methods. Its applications are essential for determining metabolic fluxes, generating kinetic and metabolite network modeling, and elucidating cellular mechanisms of action [49,50,51,52]. Stable, non-radioactive isotopes are versatile as they are naturally occurring and stable over a period of time without spontaneous decay and emission of radiation [53]. Available isotope tracers include carbon labeled (13C), deuterium (2H), and nitrogen (15N) (Figure 1). Carbon labeled is the most versatile as deuterium may decrease labeling grade during storage due to exchange of the deuterium molecule in hydrogen labile (H+) solvent [54]. Moreover, deuterium labeling on fatty acids may be lost during the desaturation phase and is unsuitable for in vivo studies [54,55]. It is also reported that the use of deuterium isotope limits the application with LC-MS due to the co-elution effects which affect the chromatographic outcomes [56]. As for nitrogen labeled, the usage is limited to nitrogen-containing molecules [54].
Isotope compounds are chemically identical but different in mass, the mass difference between the heavy isotope tracer and the naturally occurring molecule can be detected and quantified [53]. The isotopic labeling method has been used to generate an Internal Standard (IS) for compounds of interest to increase metabolite accessibility [13,14]. This has been recognized as a gold standard to produce reference standards for accurate identification and quantification of targeted metabolites [18]. This helps to reduce common issues during MS analysis, such as ionizing inefficiency and inaccuracy in metabolite quantification caused by sample co-elute matrices [15].
The isotope-labeled metabolite sample, together with a known concentration of isotope-labeled IS, enables the quantification of the absolute concentration of the desired compounds [15,21]. Direct quantitation of the metabolite of interest is achievable by the ratio comparison of the chromatogram peak intensities formed between the labeled-metabolite and IS with known concentration [21,41]. A number of tagging agents, including glucose and aniline, have been used to target different functional groups in metabolites with better selectivity while allowing universal detection of other metabolites [15].
Previous studies reported the prime isotope analog of U-13C labeled was commonly used as IS in detecting PPP metabolites, as summarized in Table 1. Chemical derivatization is proven to be effective in overcoming the common issue of poor separation of complex biological samples in chromatography analysis [12]. Tagging the metabolite with isotopes increased the hydrophobicity of the compound, thus, improving the detection and separation outcomes of liquid chromatography-mass spectrometry (LC-MS) [57]. The presence of hydrophobic elements retained polar metabolites in the column, resulting in better separation, peaks formation, and retention time [57]. The compounds or metabolites of the experimental sample are labeled with a different isotope of an identical tag (i.e., 13C-glucose, 13C-glutamine, and 1-2H or 3-2H-glucose) before the reaction is halted [13,15,48].
A step of chemical derivatization in the labeling process minimizes problems during MS analysis including in achieving the same ionization energy between standard and sample, inaccuracy in metabolite quantification due to its diversity in functional groups, and co-eluting matrix of the sample [15]. The ionization efficiency can be enhanced by adjusting the physical properties of tagged functional groups of metabolites, thus increasing the separation resolution as well as the sensitivity for LC-MS analysis [15]. Derivatization with isotope labeling also improves the detectability of low abundance molecules by increasing the mass of the molecule, therefore avoiding possible interference with the background molecules and impurities present at low m/z area [12]. In addition, compared to the conventional method of isotope synthesis of individual metabolites, isotope tagging allows simultaneous analysis of multiple samples in a single run and overcomes the limitations in obtaining commercial stable isotopes [15].

3.1. Studies of PPP Metabolism by Isotopic Tracer Method

The application of the isotope labeling technique enabled the study of metabolic fluxes and regulatory pathways of PPP in different types of cells [23,58,59,60,61,62,63,64]. 13C-glucose as the isotopic tracer is most commonly found in literature due to its versatility in tagging of metabolites [65]. Lee et al. (1998) used [1,2-13C2]-glucose to determine PPP metabolism and estimate the relative metabolite fluxes through enzymatic reactions of transaldolase and transketolase in human hepatoma cells. [1,2-13C]-glucose isotopomer was also employed to re-examine the central metabolic pathways of Clostridium acetobutylicum [60]. A study demonstrated that [2,3,4,5,6-13C]-glucose was the most suitable substrate in interpreting oxidative PPP metabolite fluxes in mammalian cells of HEK-293 cells compared to [1-13C]-glucose [61]. Clasquin et al. (2011) highlighted the use of 6-13C-glucose to elucidate the alternative mechanism of riboneogenesis in yeast to balance the needs of redox biosynthesis and homeostasis [23]. A study by Wushensky et al. (2018) successfully elucidated pathways involving PPP metabolism of B. megaterium by adding the samples into U-13C6-glucose agar plates.
Previous studies reported the use of deuterium-labeled glucose of 1-2H or 3-2H-glucose to detect the utilization of oxidative PPP metabolites in producing NADPH [62,66]. Deuterium as a tagging agent was able to overcome the limitations of carbon isotopes in allowing direct quantification of NADPH redox activity [62,66]. Furthermore, isotopic labeling has also aided in discovering unknown cellular activity in central carbon metabolism [58,64,67]. For instance, the use of 1-13C-xylose was successful in revealing the existence of alternative mechanisms in E. coli that are activated by the buildup of sedoheptu-lose-7-phosphate [64]. The purpose of the alternative process was highlighted to maintain the demands of the primary carbon metabolism fluxes [64]. In another study, labeling the Chinese hamster ovary (CHO) cells with [1,2-13C] glucose detected the upregulation of fluxes of oxidative PPP to drive transketolase like reaction and reduce oxidative stress during the stationary phase [58,67].

3.2. In Vivo Synthesis of Metabolite-Labeled Isotopes

In vivo isotope labeling is accomplished by culturing the cells or organisms in conditions containing a tagged chemical analogue of a certain natural molecular building block (e.g., amino acid, nucleotide, and carbohydrate) [68]. The presence of the chemical analog is used to label the metabolic networks and its related metabolites [57]. Stable isotope labeling is a non-radioactive approach used to detect small changes by measuring the differences in relative metabolites levels between light and heavy labeling [69,70]. Other common approaches of in vivo metabolic labeling are through radioactive labeling [71], photoreactive amino acids [72], and fluorescent probes in live cells [73]. Radioactive metabolic labeling is easy to detect and affordable, but there are concerns about safety hazards, generated waste, and toxicity [71]. Photoreactive amino acids create in vivo crosslinking via covalent bonds with any amino acid side chain or peptide bone. It does, however, have lower integration rates than isotope analogs and less tolerance over long time periods [72,74]. The use of fluorescent probes in live cells enables robust detection of signals with high sensitivity and versatility, yet requires specialized instruments for the detection of labeled metabolites [73].
Commercial isotope analogs of analytes are very limited and can be very costly, especially for metabolites of the central carbon metabolism [13,14]. In addition, the process of in vivo synthesis of the desired isotope labeling is laborious as it requires feeding the culture with U-13C-labeled substrate for a period of time and correction steps for any incomplete labeling [13,14,39,40]. The microorganism under the study is cultivated in two different mediums, with and without the 13C-labeled medium such as U-13C-glucose. Culture fed with the 13C-labeled medium serves as the IS. Rapid mixing of both cultures is then performed and proceeds for further analysis. Mashego et al. (2004) previously introduced a method known as Mass Isotopomer Ratio Analysis of U-13C-Labeled Extracts (MIRACLE). Known amounts of U-13C-labeled cells are introduced to unlabeled cell samples prior to extraction. The enrichment of heavy tagged isotopic metabolites may serve as the IS for all intracellular metabolites to be quantified [14,57]. Metabolites are quantified through peak area ratios comparison of the 12C- and U-13C-labeled metabolites samples and IS-based calibration lines [13,14]. The common ion suppression events in LC-ESI-MS/MS have no influence on the coelution peak area of the U-12C-labeled molecule to its U-13C-labeled equivalent IS in the LC [14]. Therefore, the non-linear response of electrospray ionization of MS is eliminated by the coextraction steps [14].
Incomplete tagging of metabolites has been an issue in isotopes labeling. The problem commonly occurs in a conventional labeling method when culturing the organism in U-13C-labeled medium [14]. Although incomplete or unlabeled metabolites still can be detected during analysis, the result may affect the accuracy and compromise the data. The certainty of metabolites tagging cannot be measured as some metabolites may be detected in low intensity while some structurally similar metabolites could not be differentiated by MS [41].

3.3. In Vitro Synthesis of Metabolite-Labeled Isotopes

The synthesis and labeling of metabolites with stable isotopes are possible through an in vitro process. Yang et al. (2008) developed a method known as a Group Specific Internal Standard Technology (GSIST) which applied isotopic aniline for labeling of metabolites of central carbon and energy metabolism including the PPP. Compared to common in vivo synthesis, this method is simple and able to target multiple functional groups of metabolites. Aniline as a chemical derivative tag can be used for both relative quantification of unknown compounds and absolute quantification of known compounds without requiring the addition of cultured 13C-coded internal standards prior to analysis [41]. The derivatization of isotope labeling is required and takes place at the aldehyde and phosphate groups of the sugar phosphates. Two isotope labeling agents of chemically identical but different stable isotope compositions are used such as 12C-labeled for the sample (or metabolite reference standard) while 13C-labeled for the IS.
Tagging the samples with isotope agents allows sample components to be chemically coded according to their origin [41]. The derivatization of the metabolites allows each molecule in the samples to serve as IS which helps in determining the concentration of compounds of interest in the experiment by ratio comparison of peak intensity [41]. Co-elution of identical isotope labeling agents (i.e., 12C-labeled samples and 13C-labeled IS) at the same retention times (RT) results in a pair of peaks in MS. This condition aids in distinguishing the interfering matrix, such as metabolite peaks from background signals, noise, or unlabeled metabolite signals, resulting in improved confidence and selectivity of extraction pair information [12]. The use of 12C-aniline and 13C-aniline as the tagging agents has been successfully used to identify and quantify metabolites of interest including those from PPP metabolism [21,42]. Jannasch et al. (2011) applied the similar protocol in quantifying PPP metabolites and intermediates of S. cerevisiae. Similarly, Vilkhovoy et al. (2019) successfully quantified cell-free protein synthesis (CFPS) of E. coli. The methodology adapted from the GSIST approach was capable of detecting and quantifying 40 compounds involved in the tricarboxylic acid cycle, PPP, energy metabolism, and cofactor regeneration in CFPS processes.

3.4. Aniline Tagging Method

Aniline is an aromatic amine with a colorless to slightly yellow liquid, rich in benzene derivative, and consists of a phenyl group attached to an amino group. Upon exposure to light or air, aniline may turn from a darker color of brown to red due to oxidation. The light and heavy labeling reagents of 12C6-aniline and 13C6-aniline, respectively, are prepared prior to the tagging procedure (Figure 2) [21]. Initially, an individual metabolite or compound (i.e., a commercially available metabolite reference standard) under a study is tagged with 12C6-aniline and its RT is determined to be set as a reference for the experimental sample. The IS is prepared by mixing the metabolite reference standard with the heavy label 13C6-aniline. To validate the aniline labeling reaction, the individual metabolite reference standard is labeled with aniline and the labeling pattern is observed by the spectrum in MS [41]. Experimental metabolite samples are tagged with 12C-aniline (light-labeled) and then mixed at equal ratios with the labeled-IS and further analyzed by MS. The metabolites of the sample are identified and quantified based on the peaks detected by the MS and then compared by ratio differences between the sample and the labeled IS. The samples and IS are expected to co-elute at the same RT, thus the mass difference between the two isotopes allows the distinction between the sample and IS area in the MS.
The absolute levels of metabolites are obtained by comparing the ratio between the intensity of the corresponding sample tagged with 12C6-aniline and IS tagged with 13C6-aniline peaks of the chromatograms. The results by Yang et al. (2008) indicated that the method successfully determined most of the intermediates involved in central carbon and energy metabolism of S. cerevisiae in a single run of reversed-phase LC-MS with high accuracy (RSD < 10%). In a separate study, using the same approach, structurally paired isomers of glucose-6-phosphate and fructose-6-phosphate were successfully separated in a single run of LC-MS [42]. The technique is practically used to quantify cell-free metabolism as well as whole-cell extracts [15,42]. The approach allows for the accurate identification and quantification of metabolites as the co-elution between the IS and experimental sample compounds and is able to eliminate the ion-suppression effects during LC-MS analysis [21,42]. Vilkhovoy et al. (2019) indicated that the GSIST procedure is only suitable for quantifying metabolites present in central carbon and energy metabolism, rendering it unsuitable for other essential pathways, such as amino acid and fatty acid metabolism. The method can be applied for the identification and absolute quantification of a diverse group of metabolites, including sugars, phosphosugars, carboxylic acids, nucleotides, and coenzymes.

4. Conclusions

Absolute quantification of metabolite concentration levels provides a detailed understanding towards the characteristics of metabolites as well as pathway changes under different conditions. As the method of absolute quantification has become a major challenge especially in bacterial metabolomics studies, isotope labeling coupled with MS has significantly improved the analysis. The use of a stable isotope tracer has facilitated the identification and absolute quantification of biomolecules and enhanced our understanding of metabolic fluxes. Importantly, the approach of the isotope tracer highlights the opportunity to elucidate novel cellular pathways of biological systems, such as antibiotic mechanisms of action, host–pathogen interaction, and biomarker discovery. Compared to the conventional in vivo method, an in vitro synthesis of isotope labeled-metabolites via GSIST introduced by Yang et al. (2008) allows for absolute quantification of metabolites in a more simple and robust method. The approach could serve as an alternative, especially in targeted metabolomics studies, with increased accuracy of metabolite quantification.

Author Contributions

Conceptualization, writing-review, and editing, M.H.M.M.; Writing original draft preparation, K.M.K.; Writing-review and editing, Y.Z., N.A.R., Y.Z.H.-Y.H. and M.S.A.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Ministry of Education, Malaysia under the Fundamental Research Grant Scheme (FRGS) and International Islamic University Malaysia (IIUM) (Grant No. FRGS/1/2019/STG03/UIAM/03/1 and FRGS19-119-0728).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kovářová, J.; Barrett, M.P. The pentose phosphate pathway in parasitic Trypanosomatids. Trends Parasitol. 2016, 32, 622–634. [Google Scholar] [CrossRef]
  2. Stincone, A.; Prigione, A.; Cramer, T.; Wamelink, M.M.C.; Campbell, K.; Cheung, E.; Olin-Sandoval, V.; Grüning, N.-M.; Krüger, A.; Tauqeer Alam, M.; et al. The return of metabolism: Biochemistry and physiology of the pentose phosphate pathway. Biol. Rev. 2015, 90, 927–963. [Google Scholar] [CrossRef] [Green Version]
  3. Bertels, L.K.; Murillo, L.F.; Heinisch, J.J. The pentose phosphate pathway in yeasts–more than a poor cousin of glycolysis. Biomolecules 2021, 11, 725. [Google Scholar] [CrossRef]
  4. Werner, C.; Doenst, T.; Schwarzer, M. Metabolic pathways and cycles. In The Scientist Guide to Cardiac Metabolism; Academic Press: Cambridge, MA, USA, 2016; pp. 39–55. [Google Scholar] [CrossRef]
  5. Lucarelli, G.; Galleggiante, V.; Rutigliano, M.; Sanguedolce, F.; Cagiano, S.; Bufo, P.; Lastilla, G.; Maiorano, E.; Ribatti, D.; Giglio, A.; et al. Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. Oncotarget 2015, 6, 13371–13386. [Google Scholar] [CrossRef] [Green Version]
  6. Ge, T.; Yang, J.; Zhou, S.; Wang, Y.; Li, Y.; Tong, X. The role of the pentose phosphate pathway in diabetes and cancer. Front. Endocrinol. 2020, 11, 365. [Google Scholar] [CrossRef]
  7. Luo, X.; Liu, J.; Wang, H.; Lu, H. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis. Pharmacol. Res. 2020, 156, 104805. [Google Scholar] [CrossRef]
  8. Maifiah, M.H.M.; Creek, D.J.; Nation, R.L.; Forrest, A.; Tsuji, B.T.; Velkov, T.; Li, J. Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii. Sci. Rep. 2017, 7, srep45527. [Google Scholar] [CrossRef] [Green Version]
  9. Han, M.L.; Liu, X.; Velkov, T.; Lin, Y.W.; Zhu, Y.; Li, M.; Yu, H.H.; Zhou, Z.; Creek, D.; Zhang, J.; et al. Metabolic analyses revealed time-dependent synergistic killing by colistin and aztreonam combination against multidrug-resistant Acinetobacter baumannii. Front. Microbiol. 2018, 9, 2776. [Google Scholar] [CrossRef]
  10. Zhu, Y.; Zhao, J.; Maifiah, M.H.M.; Velkov, T.; Schreiber, F.; Li, J. Metabolic responses to polymyxin treatment in Acinetobacter baumannii ATCC 19606: Integrating transcriptomics and metabolomics with genome-scale metabolic modeling. mSystems 2019, 4, e00157-18. [Google Scholar] [CrossRef]
  11. Lin, Y.W.; Han, M.L.; Zhao, J.; Zhu, Y.; Rao, G.; Forrest, A.; Song, J.; Kaye, K.S.; Hertzog, P.; Purcell, A.; et al. Synergistic combination of polymyxin B and enrofloxacin induced metabolic perturbations in extensive drug-resistant Pseudomonas aeruginosa. Front. Pharmacol. 2019, 10, 1146. [Google Scholar] [CrossRef] [Green Version]
  12. Zhao, S.; Li, L. Chemical derivatization in LC-MS-based metabolomics study. TrAC Trends Anal. Chem. 2020, 131, 115988. [Google Scholar] [CrossRef]
  13. Wu, L.; Mashego, M.R.; van Dam, J.C.; Proell, A.M.; Vinke, J.L.; Ras, C.; van Winden, W.A.; van Gulik, W.M.; Heijnen, J.J. Quantitative analysis of the microbial metabolome by isotope dilution mass spectrometry using uniformly 13C-labeled cell extracts as internal standards. Anal. Biochem. 2005, 336, 164–171. [Google Scholar] [CrossRef]
  14. Mashego, M.R.; Wu, L.; van Dam, J.C.; Ras, C.; Vinke, J.L.; van Winden, W.A.; van Gulik, W.M.; Heijnen, J.J. MIRACLE: Mass isotopomer ratio analysis of U-13C-labeled extracts. A new method for accurate quantification of changes in concentrations of intracellular metabolites. Biotechnol. Bioeng. 2004, 85, 620–628. [Google Scholar] [CrossRef]
  15. Huang, T.; Armbruster, M.R.; Coulton, J.B.; Edwards, J.L. Chemical tagging in mass spectrometry for systems biology. Anal. Chem. 2018, 91, 109–125. [Google Scholar] [CrossRef]
  16. Clendinen, C.S.; Stupp, G.S.; Ajredini, R.; Lee-McMullen, B.; Beecher, C.; Edison, A.S. An overview of methods using 13C for improved compound identification in metabolomics and natural products. Front. Plant Sci. 2015, 6, 611. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Siegrist, M.S.; Swarts, B.M.; Fox, D.M.; Lim, S.A.; Bertozzi, C.R. Illumination of growth, division and secretion by metabolic labeling of the bacterial cell surface. FEMS Microbiol. Rev. 2015, 39, 184–202. [Google Scholar] [CrossRef] [Green Version]
  18. Srivastava, A.; Kowalski, G.M.; Callahan, D.L.; Meikle, P.J.; Creek, D.J. Strategies for extending metabolomics studies with stable isotope labelling and fluxomics. Metabolites 2016, 6, 32. [Google Scholar] [CrossRef] [Green Version]
  19. Sauer, U. Metabolic networks in motion: 13C-based flux analysis. Mol. Syst. Biol. 2006, 2, 62. [Google Scholar] [CrossRef] [Green Version]
  20. Buescher, J.M.; Antoniewicz, M.R.; Boros, L.G.; Burgess, S.C.; Brunengraber, H.; Clish, C.B.; DeBerardinis, R.J.; Feron, O.; Frezza, C.; Ghesquiere, B.; et al. A roadmap for interpreting 13C metabolite labeling patterns from cells. Curr. Opin. Biotechnol. 2015, 34, 189–201. [Google Scholar] [CrossRef]
  21. Jannasch, A.; Sedlak, M.; Adamec, J. Quantification of Pentose Phosphate Pathway (PPP) Metabolites by Liquid Chromatography-Mass Spectrometry. In Metabolic Profiling; Metz, T.O., Ed.; Humana Press: Totowa, NJ, USA, 2011; Volume 708, pp. 159–171. [Google Scholar] [CrossRef]
  22. Cadière, A.; Ortiz-Julien, A.; Camarasa, C.; Dequin, S. Evolutionary engineered Saccharomyces cerevisiae wine yeast strains with increased in vivo flux through the pentose phosphate pathway. Metab. Eng. 2011, 13, 263–271. [Google Scholar] [CrossRef]
  23. Clasquin, M.F.; Melamud, E.; Singer, A.; Gooding, J.R.; Xu, X.; Dong, A.; Cui, H.; Campagna, S.R.; Savchenko, A.; Yakunin, A.F.; et al. Riboneogenesis in yeast. Cell 2011, 145, 969–980. [Google Scholar] [CrossRef] [Green Version]
  24. Zhang, Q.; Bartels, D. Octulose: A forgotten metabolite? J. Exp. Bot. 2017, 68, 5689–5694. [Google Scholar] [CrossRef] [Green Version]
  25. Jin, L.; Zhou, Y. Crucial role of the pentose phosphate pathway in malignant tumors (Review). Oncol. Lett. 2019, 17, 4213–4221. [Google Scholar] [CrossRef] [Green Version]
  26. DeBerardinis, R.J.; Sayed, N.; Ditsworth, D.; Thompson, C.B. Brick by brick: Metabolism and tumor cell growth. Curr. Opin. Genet. Dev. 2008, 18, 54–61. [Google Scholar] [CrossRef] [Green Version]
  27. Zheng, Y.; Zhu, Y.; Zhuge, T.; Li, B.; Gu, C. Metabolomics analysis discovers estrogen altering cell proliferation via the pentose phosphate pathway in infertility patient endometria. Front. Endocrinol. 2021, 12, 79114. [Google Scholar] [CrossRef]
  28. Bolaños, J.P.; Almeida, A.; Moncada, S. Glycolysis: A bioenergetic or a survival pathway? Trends Biochem. Sci. 2010, 35, 145–149. [Google Scholar] [CrossRef]
  29. Haschemi, A.; Kosma, P.; Gille, L.; Evans, C.R.; Burant, C.F.; Starkl, P.; Knapp, B.; Haas, R.; Schmid, J.A.; Jandl, C.; et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab. 2012, 15, 813–826. [Google Scholar] [CrossRef] [Green Version]
  30. Igoillo-Esteve, M.; Maugeri, D.; Stern, A.L.; Beluardi, P.; Cazzulo, J.J. The pentose phosphate pathway in Trypanosoma cruzi: A potential target for the chemotherapy of Chagas disease. An. Acad. Bras. Cien. 2007, 79, 649–663. [Google Scholar] [CrossRef]
  31. Maugeri, D.A.; Cazzulo, J.J.; Burchmore, R.J.S.; Barrett, M.P.; Ogbunude, P.O.J. Pentose phosphate metabolism in Leishmania mexicana. Mol. Biochem. Parasitol. 2003, 130, 117–125. [Google Scholar] [CrossRef]
  32. Taylor, P.L.; Blakely, K.M.; De Leon, G.P.; Walker, J.R.; McArthur, F.; Evdokimova, E.; Zhang, K.; Valvano, M.; Wright, G.; Junop, M.S. Structure and function of sedoheptulose-7-phosphate isomerase, a critical enzyme for lipopolysaccharide biosynthesis and a target for antibiotic adjuvants. J. Biol. Chem. 2008, 283, 2835–2845. [Google Scholar] [CrossRef] [Green Version]
  33. Alteri, C.J.; Mobley, H.L.T. Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr. Opin. Microbiol. 2012, 15, 3–9. [Google Scholar] [CrossRef] [Green Version]
  34. Hussein, M.; Han, M.L.; Zhu, Y.; Zhou, Q.; Lin, Y.W.; Hancock, R.E.W.; Hoyer, D.; Creek, D.J.; Li, J.; Velkov, T. Metabolomics study of the synergistic killing of polymyxin B in combination with amikacin against polymyxin-susceptible and -resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2020, 64, e01587-19. [Google Scholar] [CrossRef]
  35. Hussein, M.; Hu, X.; Paulin, O.K.A.; Crawford, S.; Zhou, Q.T.; Baker, M.; Schneider-Futschik, E.K.; Zhu, Y.; Li, J.; Velkov, T. Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens. Comput. Struct. Biotechnol. J. 2020, 18, 2247–2258. [Google Scholar] [CrossRef]
  36. Han, M.L.; Liu, X.; Velkov, T.; Lin, Y.W.; Zhu, Y.; Creek, D.J.; Barlow, C.K.; Yu, H.H.; Zhou, Z.; Zhang, J.; et al. Comparative metabolomics reveals key pathways associated with the synergistic killing of colistin and sulbactam combination against multidrug-resistant Acinetobacter baumannii. Front. Pharmacol. 2019, 10, 754. [Google Scholar] [CrossRef] [Green Version]
  37. Abdul Rahim, N.; Zhu, Y.; Cheah, S.E.; Johnson, M.D.; Yu, H.H.; Sidjabat, H.E.; Butler, M.S.; Cooper, M.A.; Fu, J.; Paterson, D.L.; et al. Synergy of the polymyxin-chloramphenicol combination against New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae is predominately driven by chloramphenicol. ACS Infect. Dis. 2021, 7, 1584–1595. [Google Scholar] [CrossRef]
  38. Hussein, M.; Han, M.L.; Zhu, Y.; Schneider-Futschik, E.K.; Hu, X.; Zhou, Q.T.; Lin, Y.-W.; Anderson, D.; Creek, D.; Hoyer, D.; et al. Mechanistic insights from global metabolomics studies into synergistic bactericidal effect of a polymyxin B combination with tamoxifen against cystic fibrosis MDR Pseudomonas aeruginosa. Comput. Struct. Biotechnol. J. 2018, 16, 587–599. [Google Scholar] [CrossRef]
  39. Creek, D.J.; Mazet, M.; Achcar, F.; Anderson, J.; Kim, D.H.; Kamour, R.; Morand, P.; Millerioux, Y.; Biran, M.; Kerkhoven, E.J.; et al. Probing the metabolic network in bloodstream-form Trypanosoma brucei using untargeted metabolomics with stable isotope labelled glucose. PLoS Pathog. 2015, 11, e1004689. [Google Scholar] [CrossRef] [Green Version]
  40. Wushensky, J.A.; Youngster, T.; Mendonca, C.M.; Aristilde, L. Flux connections between gluconate pathway, glycolysis, and pentose-phosphate pathway during carbohydrate metabolism in Bacillus megaterium QM B1551. Front. Microbiol. 2018, 9, 2789. [Google Scholar] [CrossRef]
  41. Yang, W.C.; Sedlak, M.; Regnier, F.E.; Mosier, N.; Ho, N.; Adamec, J. Simultaneous quantification of metabolites involved in central carbon and energy metabolism using reversed-phase liquid chromatography-mass spectrometry and in vitro 13C labeling. Anal. Chem. 2008, 80, 9508–9516. [Google Scholar] [CrossRef]
  42. Vilkhovoy, M.; Dai, D.; Vadhin, S.; Adhikari, A.; Varner, J.D. Absolute quantification of cell-free protein synthesis metabolism by reversed-phase liquid chromatography-mass spectrometry. J. Vis. Exp. 2019, 2019, e60329. [Google Scholar] [CrossRef]
  43. Katz, J.; Wood, H.G. The use of C14O2 yields from glucose-1- and -6-C14 for the evaluation of the pathways of glucose metabolism. J. Biol. Chem. 1963, 238, 517–523. [Google Scholar] [CrossRef]
  44. Sable, H.Z. Pentose metabolism in extracts of yeast and mammalian tissues. Biochim. Biophys. Acta 1952, 8, 687–697. [Google Scholar] [CrossRef]
  45. Novello, F.; McLean, P. The pentose phosphate pathway of glucose metabolism. Measurement of the non-oxidative reactions of the cycle. Biochem. J. 1968, 107, 775–791. [Google Scholar] [CrossRef] [Green Version]
  46. Becker, M.A. Patterns of phosphoribosylpyrophosphate and ribose 5 phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction. J. Clin. Investig. 1976, 57, 308–318. [Google Scholar] [CrossRef]
  47. King, M.T.; Passonneau, J.V.; Veech, R.L. Radiometric measurement of phosphoribosylpyrophosphate and ribose 5-phosphate by enzymatic procedures. Anal. Biochem. 1990, 187, 179–186. [Google Scholar] [CrossRef]
  48. Shih, Y.C.; Hsiao, J.T.; Sheu, F. Molecules feasibility of utilizing stable-isotope dimethyl labeling in liquid chromatography-tandem mass spectrometry-based determination for food allergens-case of Kiwifruit. Molecules 2019, 24, 1920. [Google Scholar] [CrossRef] [Green Version]
  49. Weindl, D.; Wegner, A.; Hiller, K. Metabolome-wide analysis of stable isotope labeling-Is it worth the effort? Front. Physiol. 2015, 6, 344. [Google Scholar] [CrossRef] [Green Version]
  50. Chokkathukalam, A.; Kim, D.-H.; Barrett, M.P.; Breitling, R.; Creek, D.J. Stable isotope-labeling studies in metabolomics: New insights into structure and dynamics of metabolic networks. Bioanalysis 2014, 6, 511–524. [Google Scholar] [CrossRef]
  51. Duckwall, C.; Murphy, T.; Young, J. Mapping cancer cell metabolism with 13C flux analysis: Recent progress and future challenges. J. Carcinog. 2013, 12, 13. [Google Scholar] [CrossRef]
  52. Niedenführ, S.; Wiechert, W.; Nöh, K. How to measure metabolic fluxes: A taxonomic guide for 13C fluxomics. Curr. Opin. Biotechnol. 2015, 34, 82–90. [Google Scholar] [CrossRef]
  53. Kim, I.-Y.; Suh, S.-H.; Lee, I.-K.; Wolfe, R.R. Applications of stable, nonradioactive isotope tracers in in vivo human metabolic research. Exp. Mol. Med. 2016, 48, e203. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Triebl, A.; Wenk, M.R. Biomolecules analytical considerations of stable isotope labelling in lipidomics. Biomolecules 2018, 8, 151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Grocholska, P.; Leonidov Tsakovski, S. Trends in the Hydrogen−Deuterium exchange at the carbon centers. Preparation of Internal Standards for quantitative analysis by LC-MS. Molecules 2021, 26, 2989. [Google Scholar] [CrossRef] [PubMed]
  56. Di Palma, S.; Raijmakers, R.; Heck, A.J.R.; Mohammed, S. Evaluation of the deuterium isotope effect in zwitterionic hydrophilic interaction liquid chromatography separations for implementation in a quantitative proteomic approach. Anal. Chem. 2011, 83, 8352–8356. [Google Scholar] [CrossRef]
  57. Zhao, S.; Li, L. Chemical isotope labeling LC-MS for metabolomics. In Cancer Metabolomics; Hu, S., Ed.; Springer: Cham, Switzerland, 2007; pp. 1–18. [Google Scholar]
  58. Ahn, W.S.; Crown, S.B.; Antoniewicz, M.R. Evidence for transketolase-like TKTL1 flux in CHO cells based on parallel labeling experiments and 13C-metabolic flux analysis. Metab. Eng. 2016, 37, 72–78. [Google Scholar] [CrossRef]
  59. Brekke, E.M.F.; Walls, A.B.; Schousboe, A.; Waagepetersen, H.S.; Sonnewald, U. Quantitative importance of the pentose phosphate pathway determined by incorporation of 13C from 2-13C and 3-13C glucose into TCA cycle intermediates and neurotransmitter amino acids in functionally intact neurons. J. Cereb. Blood Flow Metab. 2012, 32, 1788–1799. [Google Scholar] [CrossRef] [Green Version]
  60. Crown, S.B.; Indurthi, D.C.; Ahn, W.S.; Choi, J.; Papoutsakis, E.T.; Antoniewicz, M.R. Resolving the TCA cycle and pentose-phosphate pathway of Clostridium acetobutylicum ATCC 824 using isotopomer analysis, in vitro re-citrate synthase activities and expression analysis. Biotechnol. J. 2011, 6, 300–305. [Google Scholar] [CrossRef]
  61. Crown, S.B.; Ahn, W.S.; Antoniewicz, M.R. Rational design of 13C-labeling experiments for metabolic flux analysis in mammalian cells. BMC Syst. Biol. 2012, 6, 43. [Google Scholar] [CrossRef]
  62. Fan, J.; Ye, J.; Kamphorst, J.J.; Shlomi, T.; Thompson, C.B.; Rabinowitz, J.D. Quantitative flux analysis reveals folate-dependent NADPH production. Nature 2014, 510, 298–302. [Google Scholar] [CrossRef] [Green Version]
  63. Lee, W.N.P.; Boros, L.G.; Puigjaner, J.; Bassilian, S.; Lim, S.; Cascante, M. Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose. Am. J. Physiol. Endocrinol. Metab. 1998, 274, E843–E851. [Google Scholar] [CrossRef]
  64. Nakahigashi, K.; Toya, Y.; Ishii, N.; Soga, T.; Hasegawa, M.; Watanabe, H.; Takai, Y.; Honma, M.; Mori, H.; Tomita, M. Systematic phenome analysis of Escherichia coli multiple-knockout mutants reveals hidden reactions in central carbon metabolism. Mol. Syst. Biol. 2009, 5, 306. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Antoniewicz, M.R. A guide to 13C metabolic flux analysis for the cancer biologist. Exp. Mol. Med. 2018, 50, 1–13. [Google Scholar] [CrossRef] [Green Version]
  66. Lewis, C.A.; Parker, S.J.; Fiske, B.P.; McCloskey, D.; Gui, D.Y.; Green, C.R.; Vokes, N.I.; Feist, A.M.; Heiden, M.G.V.; Metallo, C.M. Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. Mol. Cell 2014, 55, 253–263. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Ahn, W.S.; Antoniewicz, M.R. Metabolic flux analysis of CHO cells at growth and non-growth phases using isotopic tracers and mass spectrometry. Metab. Eng. 2011, 13, 598–609. [Google Scholar] [CrossRef] [PubMed]
  68. Metabolic labeling and chemoselective ligation|Thermo Fisher Scientific—MY. Available online: https://www.thermofisher.com/my/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/metabolic-labeling-chemoselective-ligation.html (accessed on 22 April 2022).
  69. Ong, S.E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D.B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376–386. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Klein, S.; Heinzle, E. Isotope labeling experiments in metabolomics and fluxomics. WIREs Syst. Biol. Med. 2012, 4, 261–272. [Google Scholar] [CrossRef]
  71. Paul Lee, W.N.; Wahjudi, P.N.; Xu, J.; Go, V.L. Tracer-based Metabolomics: Concepts and Practices. Clin. Biochem. 2010, 43, 1269–1277. [Google Scholar] [CrossRef] [Green Version]
  72. Suchanek, M.; Radzikowska, A.; Thiele, C. Photo-leucine and photo-methionine allow identification of protein-protein interactions in living cells. Nat. Methods 2005, 2, 261–268. [Google Scholar] [CrossRef] [Green Version]
  73. Crivat, G.; Taraska, J.W. Imaging proteins inside cells with fluorescent tags. Trends Biotechnol. 2012, 30, 8–16. [Google Scholar] [CrossRef] [Green Version]
  74. Rappsilber, J. The beginning of a beautiful friendship: Cross-linking/mass spectrometry and modelling of proteins and multi-protein complexes. J. Struct. Biol. 2011, 173, 530–540. [Google Scholar] [CrossRef]
Metabolites 12 01085 g001 550
Figure 1. Examples of commercial stable isotope tracers of carbon (13C), nitrogen (15N), and deuterium (2H).
Figure 1. Examples of commercial stable isotope tracers of carbon (13C), nitrogen (15N), and deuterium (2H).
Metabolites 12 01085 g001
Metabolites 12 01085 g002 550
Figure 2. Strategy of aniline tagging method. (A) Preparation steps for stable isotope labeling of aniline for experimental samples and internal standards. (B) Tagging of PPP metabolites with aniline isotope. For R5P and E4P, one mole of aniline is attached to the phosphate and aldose groups, respectively. For S7P, only one mole of aniline is attached to the phosphate group.
Figure 2. Strategy of aniline tagging method. (A) Preparation steps for stable isotope labeling of aniline for experimental samples and internal standards. (B) Tagging of PPP metabolites with aniline isotope. For R5P and E4P, one mole of aniline is attached to the phosphate and aldose groups, respectively. For S7P, only one mole of aniline is attached to the phosphate group.
Metabolites 12 01085 g002
Table
Table 1. Absolute quantification of pentose phosphate pathway (PPP) metabolites of microbial samples using the isotope labeling method.
Table 1. Absolute quantification of pentose phosphate pathway (PPP) metabolites of microbial samples using the isotope labeling method.
Isotopic TracerSampleMethodPPP MetabolitesReference
U-13C labeled mediumSaccharomyces cerevisiaeRapid sampling and mix of chemostat labeled with 12C-labeled steady state glucose and 13C-labeled.G6P, F6P[14]
U-13C6-glucoseS. cerevisiaeFeed the culture with U-13C6-glucose and the sample is added to the unlabeled calibration standards as IS.G6P, F6P[13]
U-12C and U-13C-glucoseTrypanosoma bruceiReplacing the growth media with media containing 12C-labeled and 13C-labeled glucose.R5P, F6P[39]
U-13C6-glucoseBacillus megateriumAddition of sample into U-13C6-glucose agar plates, followed by the continuation of the culture at regular intervals for isotopic switchesG6P, F6P, 6PG, R5P, S7P, E4P[40]
12C6- aniline and 13C6-anilineS. cerevisiaeTagging of internal standards with 13C6-aniline and derivatization of compounds in the sample with 12C6-anilineG6P, F6P, DR5P, G3P, DE4P, DR5P[41]
S. cerevisiaeG6P, F6P, DR5P, G3P, 6PG, DE4P, DR5P, DS7P, X5P[21]
Escherichia coliG6P, F6P, DR5P, G3P, 6PG, DE4P, DR5P, DS7P[42]
G6P: Glucose 6-phosphate; F6P: Fructose 6-phosphate; R5P/DR5P: Ribose 5-phosphate/D-ribose 5-phosphate; 6PG: 6-phosphogluconate; S7P/DS7P: Sedoheptulose 7-phosphate/D-sedoheptulose-7-phosphate; E4P/DE4P: Erythrose 4-phosphate/D-erythrose 4-phosphate; X5P: Xylulose 5-phosphate; G3P: Glyceraldehyde 3-phosphate.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mohd Kamal, K.; Mahamad Maifiah, M.H.; Zhu, Y.; Abdul Rahim, N.; Hashim, Y.Z.H.-Y.; Abdullah Sani, M.S. Isotopic Tracer for Absolute Quantification of Metabolites of the Pentose Phosphate Pathway in Bacteria. Metabolites 2022, 12, 1085. https://doi.org/10.3390/metabo12111085

AMA Style

Mohd Kamal K, Mahamad Maifiah MH, Zhu Y, Abdul Rahim N, Hashim YZH-Y, Abdullah Sani MS. Isotopic Tracer for Absolute Quantification of Metabolites of the Pentose Phosphate Pathway in Bacteria. Metabolites. 2022; 12(11):1085. https://doi.org/10.3390/metabo12111085

Chicago/Turabian Style

Mohd Kamal, Khairunnisa, Mohd Hafidz Mahamad Maifiah, Yan Zhu, Nusaibah Abdul Rahim, Yumi Zuhanis Has-Yun Hashim, and Muhamad Shirwan Abdullah Sani. 2022. "Isotopic Tracer for Absolute Quantification of Metabolites of the Pentose Phosphate Pathway in Bacteria" Metabolites 12, no. 11: 1085. https://doi.org/10.3390/metabo12111085

APA Style

Mohd Kamal, K., Mahamad Maifiah, M. H., Zhu, Y., Abdul Rahim, N., Hashim, Y. Z. H. -Y., & Abdullah Sani, M. S. (2022). Isotopic Tracer for Absolute Quantification of Metabolites of the Pentose Phosphate Pathway in Bacteria. Metabolites, 12(11), 1085. https://doi.org/10.3390/metabo12111085

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop